JP2020505000A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020505000A5 JP2020505000A5 JP2019532936A JP2019532936A JP2020505000A5 JP 2020505000 A5 JP2020505000 A5 JP 2020505000A5 JP 2019532936 A JP2019532936 A JP 2019532936A JP 2019532936 A JP2019532936 A JP 2019532936A JP 2020505000 A5 JP2020505000 A5 JP 2020505000A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- sequence
- protein
- acid sequence
- target nucleic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 claims description 112
- 102000004169 proteins and genes Human genes 0.000 claims description 110
- 150000007523 nucleic acids Chemical group 0.000 claims description 72
- 102000040430 polynucleotide Human genes 0.000 claims description 49
- 108091033319 polynucleotide Proteins 0.000 claims description 49
- 239000002157 polynucleotide Substances 0.000 claims description 49
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 48
- 210000004027 cell Anatomy 0.000 claims description 45
- 238000000034 method Methods 0.000 claims description 34
- 238000012986 modification Methods 0.000 claims description 34
- 230000004048 modification Effects 0.000 claims description 34
- 108020004414 DNA Proteins 0.000 claims description 33
- 238000003776 cleavage reaction Methods 0.000 claims description 31
- 230000007017 scission Effects 0.000 claims description 31
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 29
- 230000027455 binding Effects 0.000 claims description 29
- 238000009739 binding Methods 0.000 claims description 29
- 238000002372 labelling Methods 0.000 claims description 29
- 230000008685 targeting Effects 0.000 claims description 29
- 102000007999 Nuclear Proteins Human genes 0.000 claims description 28
- 108010089610 Nuclear Proteins Proteins 0.000 claims description 28
- 101710163270 Nuclease Proteins 0.000 claims description 23
- 102000011931 Nucleoproteins Human genes 0.000 claims description 21
- 108010061100 Nucleoproteins Proteins 0.000 claims description 21
- 102000053602 DNA Human genes 0.000 claims description 20
- 241000894006 Bacteria Species 0.000 claims description 13
- 125000003729 nucleotide group Chemical group 0.000 claims description 13
- 108010043121 Green Fluorescent Proteins Proteins 0.000 claims description 10
- 102000004144 Green Fluorescent Proteins Human genes 0.000 claims description 10
- 239000005090 green fluorescent protein Substances 0.000 claims description 10
- 210000005260 human cell Anatomy 0.000 claims description 10
- 239000003550 marker Substances 0.000 claims description 9
- 102000039446 nucleic acids Human genes 0.000 claims description 9
- 108020004707 nucleic acids Proteins 0.000 claims description 9
- 108010013043 Acetylesterase Proteins 0.000 claims description 8
- 108091033409 CRISPR Proteins 0.000 claims description 8
- 102100025169 Max-binding protein MNT Human genes 0.000 claims description 8
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 8
- 108091006107 transcriptional repressors Proteins 0.000 claims description 8
- 230000000295 complement effect Effects 0.000 claims description 7
- 230000000694 effects Effects 0.000 claims description 7
- 230000030279 gene silencing Effects 0.000 claims description 7
- 108060004795 Methyltransferase Proteins 0.000 claims description 6
- -1 optionally Proteins 0.000 claims description 6
- 241000894007 species Species 0.000 claims description 6
- 241000203069 Archaea Species 0.000 claims description 5
- 102000052510 DNA-Binding Proteins Human genes 0.000 claims description 5
- 101710096438 DNA-binding protein Proteins 0.000 claims description 5
- 108010036115 Histone Methyltransferases Proteins 0.000 claims description 5
- 102000011787 Histone Methyltransferases Human genes 0.000 claims description 5
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 claims description 5
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 claims description 5
- 102000001253 Protein Kinase Human genes 0.000 claims description 5
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 5
- 108091028113 Trans-activating crRNA Proteins 0.000 claims description 5
- 241000700605 Viruses Species 0.000 claims description 5
- 239000012190 activator Substances 0.000 claims description 5
- 238000001261 affinity purification Methods 0.000 claims description 5
- 102000023732 binding proteins Human genes 0.000 claims description 5
- 108091008324 binding proteins Proteins 0.000 claims description 5
- 108091006047 fluorescent proteins Proteins 0.000 claims description 5
- 102000034287 fluorescent proteins Human genes 0.000 claims description 5
- 238000012226 gene silencing method Methods 0.000 claims description 5
- 239000003446 ligand Substances 0.000 claims description 5
- 108060006633 protein kinase Proteins 0.000 claims description 5
- 230000002103 transcriptional effect Effects 0.000 claims description 5
- 238000010354 CRISPR gene editing Methods 0.000 claims description 4
- 239000013604 expression vector Substances 0.000 claims description 4
- 210000001236 prokaryotic cell Anatomy 0.000 claims description 4
- 241001468175 Geobacillus thermodenitrificans Species 0.000 claims description 2
- 125000006850 spacer group Chemical group 0.000 claims description 2
- 230000030570 cellular localization Effects 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 description 7
- 230000014509 gene expression Effects 0.000 description 6
- 241000626621 Geobacillus Species 0.000 description 5
- 210000004899 c-terminal region Anatomy 0.000 description 5
- 230000005782 double-strand break Effects 0.000 description 4
- 230000003834 intracellular effect Effects 0.000 description 4
- 230000007018 DNA scission Effects 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000005783 single-strand break Effects 0.000 description 3
- 108091006106 transcriptional activators Proteins 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 238000010362 genome editing Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022121297A JP2022166045A (ja) | 2016-12-14 | 2022-07-29 | 熱安定性ｃａｓ９ヌクレアーゼ |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EPPCT/EP2016/081077 | 2016-12-14 | ||
| PCT/EP2016/081077 WO2018108272A1 (en) | 2016-12-14 | 2016-12-14 | Thermostable cas9 nucleases |
| PCT/EP2017/070796 WO2018108338A1 (en) | 2016-12-14 | 2017-08-16 | Thermostable cas9 nucleases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022121297A Division JP2022166045A (ja) | 2016-12-14 | 2022-07-29 | 熱安定性ｃａｓ９ヌクレアーゼ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020505000A JP2020505000A (ja) | 2020-02-20 |
| JP2020505000A5 true JP2020505000A5 (enExample) | 2020-09-24 |
| JP7223376B2 JP7223376B2 (ja) | 2023-02-16 |
Family
ID=57755254
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019533096A Active JP7182545B2 (ja) | 2016-12-14 | 2016-12-14 | 熱安定性ｃａｓ９ヌクレアーゼ |
| JP2019533103A Active JP7223377B2 (ja) | 2016-12-14 | 2017-08-16 | 熱安定性ｃａｓ９ヌクレアーゼ |
| JP2019532936A Active JP7223376B2 (ja) | 2016-12-14 | 2017-08-16 | 熱安定性ｃａｓ９ヌクレアーゼ |
| JP2019533098A Active JP7283698B2 (ja) | 2016-12-14 | 2017-12-14 | 熱安定性ｃａｓ９ヌクレアーゼ |
| JP2022121297A Withdrawn JP2022166045A (ja) | 2016-12-14 | 2022-07-29 | 熱安定性ｃａｓ９ヌクレアーゼ |
| JP2022128902A Withdrawn JP2022166170A (ja) | 2016-12-14 | 2022-08-12 | 熱安定性ｃａｓ９ヌクレアーゼ |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019533096A Active JP7182545B2 (ja) | 2016-12-14 | 2016-12-14 | 熱安定性ｃａｓ９ヌクレアーゼ |
| JP2019533103A Active JP7223377B2 (ja) | 2016-12-14 | 2017-08-16 | 熱安定性ｃａｓ９ヌクレアーゼ |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019533098A Active JP7283698B2 (ja) | 2016-12-14 | 2017-12-14 | 熱安定性ｃａｓ９ヌクレアーゼ |
| JP2022121297A Withdrawn JP2022166045A (ja) | 2016-12-14 | 2022-07-29 | 熱安定性ｃａｓ９ヌクレアーゼ |
| JP2022128902A Withdrawn JP2022166170A (ja) | 2016-12-14 | 2022-08-12 | 熱安定性ｃａｓ９ヌクレアーゼ |
Country Status (11)
| Country | Link |
|---|---|
| US (5) | US11242513B2 (enExample) |
| EP (4) | EP3555275A1 (enExample) |
| JP (6) | JP7182545B2 (enExample) |
| KR (4) | KR102913446B1 (enExample) |
| CN (4) | CN110312792B (enExample) |
| AU (4) | AU2016432443B2 (enExample) |
| BR (3) | BR112019012155A2 (enExample) |
| CA (4) | CA3046824A1 (enExample) |
| EA (4) | EA201991443A1 (enExample) |
| PH (4) | PH12019501335A1 (enExample) |
| WO (3) | WO2018108272A1 (enExample) |
Families Citing this family (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2734621B1 (en) | 2011-07-22 | 2019-09-04 | President and Fellows of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
| US9637739B2 (en) * | 2012-03-20 | 2017-05-02 | Vilnius University | RNA-directed DNA cleavage by the Cas9-crRNA complex |
| US9163284B2 (en) | 2013-08-09 | 2015-10-20 | President And Fellows Of Harvard College | Methods for identifying a target site of a Cas9 nuclease |
| US9359599B2 (en) | 2013-08-22 | 2016-06-07 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
| US9322037B2 (en) | 2013-09-06 | 2016-04-26 | President And Fellows Of Harvard College | Cas9-FokI fusion proteins and uses thereof |
| US9340800B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | Extended DNA-sensing GRNAS |
| US9526784B2 (en) | 2013-09-06 | 2016-12-27 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
| US20150165054A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting caspase-9 point mutations |
| CA2956224A1 (en) | 2014-07-30 | 2016-02-11 | President And Fellows Of Harvard College | Cas9 proteins including ligand-dependent inteins |
| EP3204496A1 (en) | 2014-10-10 | 2017-08-16 | Editas Medicine, Inc. | Compositions and methods for promoting homology directed repair |
| US11680268B2 (en) | 2014-11-07 | 2023-06-20 | Editas Medicine, Inc. | Methods for improving CRISPR/Cas-mediated genome-editing |
| CA2986310A1 (en) | 2015-05-11 | 2016-11-17 | Editas Medicine, Inc. | Optimized crispr/cas9 systems and methods for gene editing in stem cells |
| WO2016201047A1 (en) | 2015-06-09 | 2016-12-15 | Editas Medicine, Inc. | Crispr/cas-related methods and compositions for improving transplantation |
| GB201510296D0 (en) * | 2015-06-12 | 2015-07-29 | Univ Wageningen | Thermostable CAS9 nucleases |
| EP3786294A1 (en) | 2015-09-24 | 2021-03-03 | Editas Medicine, Inc. | Use of exonucleases to improve crispr/cas-mediated genome editing |
| EP4434589A3 (en) | 2015-10-23 | 2025-05-14 | President and Fellows of Harvard College | Evolved cas9 proteins for gene editing |
| US11597924B2 (en) | 2016-03-25 | 2023-03-07 | Editas Medicine, Inc. | Genome editing systems comprising repair-modulating enzyme molecules and methods of their use |
| WO2017180694A1 (en) | 2016-04-13 | 2017-10-19 | Editas Medicine, Inc. | Cas9 fusion molecules gene editing systems, and methods of use thereof |
| JP7231935B2 (ja) | 2016-08-03 | 2023-03-08 | プレジデント アンド フェローズ オブ ハーバード カレッジ | アデノシン核酸塩基編集因子およびそれらの使用 |
| US11661590B2 (en) | 2016-08-09 | 2023-05-30 | President And Fellows Of Harvard College | Programmable CAS9-recombinase fusion proteins and uses thereof |
| WO2018039438A1 (en) | 2016-08-24 | 2018-03-01 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
| AU2017342543B2 (en) | 2016-10-14 | 2024-06-27 | President And Fellows Of Harvard College | AAV delivery of nucleobase editors |
| US11242513B2 (en) | 2016-12-14 | 2022-02-08 | Wageningen Universiteit | Thermostable Cas9 nucleases |
| WO2018119010A1 (en) | 2016-12-19 | 2018-06-28 | Editas Medicine, Inc. | Assessing nuclease cleavage |
| WO2018119359A1 (en) | 2016-12-23 | 2018-06-28 | President And Fellows Of Harvard College | Editing of ccr5 receptor gene to protect against hiv infection |
| WO2018129368A2 (en) | 2017-01-06 | 2018-07-12 | Editas Medicine, Inc. | Methods of assessing nuclease cleavage |
| US11898179B2 (en) | 2017-03-09 | 2024-02-13 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
| CN110662556A (zh) | 2017-03-09 | 2020-01-07 | 哈佛大学的校长及成员们 | 癌症疫苗 |
| JP2020510439A (ja) | 2017-03-10 | 2020-04-09 | プレジデント アンド フェローズ オブ ハーバード カレッジ | シトシンからグアニンへの塩基編集因子 |
| WO2018176009A1 (en) | 2017-03-23 | 2018-09-27 | President And Fellows Of Harvard College | Nucleobase editors comprising nucleic acid programmable dna binding proteins |
| EP3615672A1 (en) | 2017-04-28 | 2020-03-04 | Editas Medicine, Inc. | Methods and systems for analyzing guide rna molecules |
| US11560566B2 (en) | 2017-05-12 | 2023-01-24 | President And Fellows Of Harvard College | Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation |
| EP3635104A1 (en) | 2017-06-09 | 2020-04-15 | Editas Medicine, Inc. | Engineered cas9 nucleases |
| WO2019014564A1 (en) | 2017-07-14 | 2019-01-17 | Editas Medicine, Inc. | SYSTEMS AND METHODS OF TARGETED INTEGRATION AND GENOME EDITING AND DETECTION THEREOF WITH INTEGRATED PRIMING SITES |
| US11732274B2 (en) | 2017-07-28 | 2023-08-22 | President And Fellows Of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE) |
| WO2019139645A2 (en) | 2017-08-30 | 2019-07-18 | President And Fellows Of Harvard College | High efficiency base editors comprising gam |
| GB201716590D0 (en) * | 2017-10-10 | 2017-11-22 | Univ Wageningen | Thermostable cas9 nucleases with reduced off-target activity |
| KR20200121782A (ko) | 2017-10-16 | 2020-10-26 | 더 브로드 인스티튜트, 인코퍼레이티드 | 아데노신 염기 편집제의 용도 |
| US12406749B2 (en) | 2017-12-15 | 2025-09-02 | The Broad Institute, Inc. | Systems and methods for predicting repair outcomes in genetic engineering |
| KR102684890B1 (ko) * | 2018-02-15 | 2024-07-12 | 시그마-알드리치 컴퍼니., 엘엘씨 | 진핵 게놈 변형을 위한 조작된 cas9 시스템 |
| US12157760B2 (en) | 2018-05-23 | 2024-12-03 | The Broad Institute, Inc. | Base editors and uses thereof |
| AU2019291918B2 (en) | 2018-06-29 | 2025-06-12 | Editas Medicine, Inc. | Synthetic guide molecules, compositions and methods relating thereto |
| US12522807B2 (en) | 2018-07-09 | 2026-01-13 | The Broad Institute, Inc. | RNA programmable epigenetic RNA modifiers and uses thereof |
| WO2020092453A1 (en) | 2018-10-29 | 2020-05-07 | The Broad Institute, Inc. | Nucleobase editors comprising geocas9 and uses thereof |
| JP2022505440A (ja) | 2018-11-01 | 2022-01-14 | キージーン ナムローゼ フェンノートシャップ | 植物細胞におけるＣＲＩＳＰＲ／Ｃａｓゲノム編集のためのデュアルガイドＲＮＡ |
| US12305218B2 (en) * | 2018-11-16 | 2025-05-20 | Depixus | Optimization of in vitro isolation of nucleic acids using site-specific nucleases |
| RU2712497C1 (ru) * | 2018-11-26 | 2020-01-29 | Автономная некоммерческая образовательная организация высшего образования Сколковский институт науки и технологий | Средство разрезания ДНК на основе Cas9 белка из биотехнологически значимой бактерии Clostridium cellulolyticum |
| WO2020154500A1 (en) | 2019-01-23 | 2020-07-30 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| AU2020221274B2 (en) | 2019-02-15 | 2024-02-08 | Sigma-Aldrich Co. Llc. | Crispr/Cas fusion proteins and systems |
| MX2021011426A (es) | 2019-03-19 | 2022-03-11 | Broad Inst Inc | Metodos y composiciones para editar secuencias de nucleótidos. |
| WO2020214842A1 (en) | 2019-04-17 | 2020-10-22 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| CN116694603A (zh) * | 2019-05-14 | 2023-09-05 | 深圳华大生命科学研究院 | 新型的Cas蛋白、Crispr-Cas系统及其在基因编辑领域中的用途 |
| CN110331158B (zh) * | 2019-07-30 | 2021-09-14 | 湖北大学 | 基于运动发酵单胞菌内源CRISPR-Cas系统的多基因位点同时编辑方法及其应用 |
| WO2021017200A1 (zh) * | 2019-07-30 | 2021-02-04 | 湖北大学 | 一种基于运动发酵单胞菌的CRISPR-Cas系统、基因组编辑体系及其应用 |
| WO2021032180A1 (zh) * | 2019-08-21 | 2021-02-25 | 江南大学 | 一种多靶点编辑重组曲霉菌株的可视化筛选方法 |
| US11879134B1 (en) * | 2019-09-05 | 2024-01-23 | The Regents Of The University Of Colorado, A Body Corporate | Recombineering machinery to increase homology directed genome editing in thermophilic microbes |
| US12435330B2 (en) | 2019-10-10 | 2025-10-07 | The Broad Institute, Inc. | Methods and compositions for prime editing RNA |
| WO2021226558A1 (en) | 2020-05-08 | 2021-11-11 | The Broad Institute, Inc. | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
| CN111778230A (zh) * | 2020-07-17 | 2020-10-16 | 山东舜丰生物科技有限公司 | 一种适用于Cas12蛋白的缓冲系统及其应用 |
| RU2749307C1 (ru) * | 2020-10-30 | 2021-06-08 | Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский институт сельскохозяйственной биотехнологии" (ФГБНУ ВНИИСБ) | Новая компактная нуклеаза CAS9 II типа из Anoxybacillus flavithermus |
| CN113881652B (zh) * | 2020-11-11 | 2022-11-22 | 山东舜丰生物科技有限公司 | 新型Cas酶和系统以及应用 |
| CN114480347B (zh) * | 2022-02-21 | 2022-12-23 | 中国科学院地球化学研究所 | 一种纯化Cas12a蛋白的方法 |
| CN114934031B (zh) * | 2022-05-25 | 2023-08-01 | 广州瑞风生物科技有限公司 | 新型Cas效应蛋白、基因编辑系统及用途 |
| JP7152094B1 (ja) * | 2022-06-30 | 2022-10-12 | リージョナルフィッシュ株式会社 | ｔｒａｃｒＲＮＡユニット、及びゲノム編集方法 |
| CN117701530A (zh) * | 2022-12-08 | 2024-03-15 | 广州瑞风生物科技有限公司 | Cas蛋白截短体、构建其的方法及其应用 |
| CN116144631B (zh) * | 2023-01-17 | 2023-09-15 | 华中农业大学 | 耐热型核酸内切酶及其介导的基因编辑系统 |
| CN118773168B (zh) * | 2023-11-24 | 2025-07-25 | 华智生物技术有限公司 | CRISPR/Cas效应蛋白HT001及系统与应用 |
| US20250250641A1 (en) * | 2024-02-06 | 2025-08-07 | Florida State University Research Foundation, Inc. | Methods and compositions related to epigenetic editing by a methlylation-dependent cas9 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2176082B1 (es) | 2000-05-31 | 2004-01-01 | Consejo Superior Investigacion | Bacterias con la capacidad de unir metales pesados y su empleo en la detoxificacion de medios contaminados con metales pesados. |
| US7220571B2 (en) | 2000-09-28 | 2007-05-22 | Archer-Daniels-Midland Company | Escherichia coli strains which over-produce L-threonine and processes for the production of L-threonine by fermentation |
| WO2002066622A2 (en) * | 2001-02-23 | 2002-08-29 | Novozymes A/S | Method of generating diversity into lipolytic enzymes and lipolytic enzyme genes |
| US7670807B2 (en) | 2004-03-10 | 2010-03-02 | East Tennessee State Univ. Research Foundation | RNA-dependent DNA polymerase from Geobacillus stearothermophilus |
| JP2006230303A (ja) | 2005-02-25 | 2006-09-07 | Art Engineering Kk | 好熱性リパーゼ産生菌およびその利用 |
| KR100872695B1 (ko) | 2006-11-27 | 2008-12-10 | 씨제이제일제당 (주) | Ｇｒａｓ 미생물로부터 발현된 식품안전형 호열성아라비노스 이성화효소 및 그를 이용한 타가토스의제조방법 |
| EP2468869B1 (en) * | 2007-01-31 | 2015-03-18 | Pfenex Inc. | Bacterial leader sequences for increased expression |
| BR112012006941A2 (pt) | 2009-09-29 | 2015-09-08 | Butamax Tm Advanced Biofuels | célula bacteriana de ácido recombinante, método de produção de uma célula bacteriana do ácido lético recombinamte, método de produção de isobutanol, vetor de integração de bastérias do ácido lático e método para integrar aleatoriamente um segmento de dna em uma célula bacteriana do ácido lético genoma |
| PL4289948T3 (pl) | 2012-05-25 | 2025-06-02 | The Regents Of The University Of California | Sposoby i kompozycje do modyfikacji kierowanego na rna docelowego dna i do nakierowanej na rna modulacji transkrypcji |
| UA120033C2 (uk) | 2013-03-15 | 2019-09-25 | Сібас Юс Ллс | Спосіб підвищення ефективності спрямованої модифікації генів із застосуванням опосередкованої олігонуклеотидами репарації генів |
| AU2015229095B2 (en) | 2014-03-14 | 2022-01-27 | Cibus Europe B.V. | Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair |
| US10725041B2 (en) | 2014-11-04 | 2020-07-28 | Versiti Blood Research Institute Foundation, Inc. | Method to bioengineer designer platelets using gene editing and stem cell methodologies |
| US11680268B2 (en) | 2014-11-07 | 2023-06-20 | Editas Medicine, Inc. | Methods for improving CRISPR/Cas-mediated genome-editing |
| CA2971391C (en) | 2014-12-17 | 2023-05-09 | E. I. Du Pont De Nemours And Company | Compositions and methods for efficient gene editing in e. coli using guide rna/cas endonuclease systems in combination with circular polynucleotide modification templates. |
| US20160346359A1 (en) * | 2015-05-01 | 2016-12-01 | Spark Therapeutics, Inc. | Adeno-associated Virus-Mediated CRISPR-Cas9 Treatment of Ocular Disease |
| BR112017024534A2 (pt) * | 2015-05-15 | 2018-07-24 | Pioneer Hi Bred Int | sistemas de rna-guia/endonuclease cas9 inovadores |
| GB201510296D0 (en) * | 2015-06-12 | 2015-07-29 | Univ Wageningen | Thermostable CAS9 nucleases |
| US11242513B2 (en) | 2016-12-14 | 2022-02-08 | Wageningen Universiteit | Thermostable Cas9 nucleases |
-
2016
- 2016-12-14 US US16/469,674 patent/US11242513B2/en active Active
- 2016-12-14 WO PCT/EP2016/081077 patent/WO2018108272A1/en not_active Ceased
- 2016-12-14 BR BR112019012155-2A patent/BR112019012155A2/pt active Search and Examination
- 2016-12-14 AU AU2016432443A patent/AU2016432443B2/en active Active
- 2016-12-14 EA EA201991443A patent/EA201991443A1/ru unknown
- 2016-12-14 CA CA3046824A patent/CA3046824A1/en active Pending
- 2016-12-14 CN CN201680092098.5A patent/CN110312792B/zh active Active
- 2016-12-14 KR KR1020197020534A patent/KR102913446B1/ko active Active
- 2016-12-14 EP EP16822931.8A patent/EP3555275A1/en active Pending
- 2016-12-14 JP JP2019533096A patent/JP7182545B2/ja active Active
-
2017
- 2017-08-16 CA CA3046826A patent/CA3046826A1/en active Pending
- 2017-08-16 EA EA201991442A patent/EA201991442A1/ru unknown
- 2017-08-16 US US16/469,683 patent/US11976306B2/en active Active
- 2017-08-16 CN CN201780086540.8A patent/CN110382693B/zh active Active
- 2017-08-16 JP JP2019533103A patent/JP7223377B2/ja active Active
- 2017-08-16 BR BR112019012173-0A patent/BR112019012173A2/pt unknown
- 2017-08-16 AU AU2017377136A patent/AU2017377136B2/en active Active
- 2017-08-16 US US16/469,677 patent/US11326162B2/en active Active
- 2017-08-16 WO PCT/EP2017/070797 patent/WO2018108339A1/en not_active Ceased
- 2017-08-16 EP EP17761030.0A patent/EP3555277A1/en active Pending
- 2017-08-16 CN CN201780086541.2A patent/CN110352241B/zh active Active
- 2017-08-16 EA EA201991440A patent/EA201991440A1/ru unknown
- 2017-08-16 KR KR1020197020536A patent/KR102523543B1/ko active Active
- 2017-08-16 WO PCT/EP2017/070796 patent/WO2018108338A1/en not_active Ceased
- 2017-08-16 EP EP17757728.5A patent/EP3555276A1/en active Pending
- 2017-08-16 AU AU2017377135A patent/AU2017377135B2/en active Active
- 2017-08-16 JP JP2019532936A patent/JP7223376B2/ja active Active
- 2017-08-16 KR KR1020197020535A patent/KR102523544B1/ko active Active
- 2017-08-16 CA CA3046828A patent/CA3046828A1/en active Pending
- 2017-12-14 BR BR112019012183-8A patent/BR112019012183A2/pt active Search and Examination
- 2017-12-14 AU AU2017377792A patent/AU2017377792B2/en active Active
- 2017-12-14 KR KR1020197020537A patent/KR102662270B1/ko active Active
- 2017-12-14 EA EA201991441A patent/EA201991441A1/ru unknown
- 2017-12-14 CA CA3046842A patent/CA3046842A1/en active Pending
- 2017-12-14 CN CN201780086546.5A patent/CN110431229B/zh active Active
- 2017-12-14 US US16/469,691 patent/US12071639B2/en active Active
- 2017-12-14 EP EP17829169.6A patent/EP3555278B1/en active Active
- 2017-12-14 JP JP2019533098A patent/JP7283698B2/ja active Active
-
2019
- 2019-06-13 PH PH12019501335A patent/PH12019501335A1/en unknown
- 2019-06-13 PH PH12019501346A patent/PH12019501346A1/en unknown
- 2019-06-13 PH PH12019501340A patent/PH12019501340A1/en unknown
- 2019-06-13 PH PH12019501344A patent/PH12019501344A1/en unknown
-
2022
- 2022-01-14 US US17/575,952 patent/US11939605B2/en active Active
- 2022-07-29 JP JP2022121297A patent/JP2022166045A/ja not_active Withdrawn
- 2022-08-12 JP JP2022128902A patent/JP2022166170A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020505000A5 (enExample) | ||
| JP2020510410A5 (enExample) | ||
| US11802277B2 (en) | Thermostable Cas9 nucleases | |
| US20250230424A1 (en) | Modified cascade ribonucleoproteins and uses thereof | |
| JP2023002712A (ja) | Ｓ．ピオゲネスｃａｓ９変異遺伝子及びこれによってコードされるポリペプチド | |
| JP6715419B2 (ja) | カンピロバクター・ジェジュニｃｒｉｓｐｒ／ｃａｓシステムに由来するｒｇｅｎを使用したゲノム編集 | |
| JP2019534704A (ja) | エピジェネティックに調節される部位特異的ヌクレアーゼ | |
| JP2015503535A5 (enExample) | ||
| US20220389418A1 (en) | Rna-guided cas nucleases and uses thereof in diagnostics and therapy | |
| US20240247255A1 (en) | Methods for modulating cas-effector activity | |
| WO2022210748A1 (ja) | 新規なガイドｒｎａとの複合体形成能を有するポリペプチド | |
| CN117487831A (zh) | 鉴定AcrIIA31蛋白并应用于调控CRISPR-Cas9基因编辑的方法 | |
| US20250223578A1 (en) | Modified cascade ribonucleoproteins and uses thereof | |
| CA2989084C (en) | Thermostable cas9 nucleases | |
| HK1231119B (en) | Modified cascade ribonucleoproteins and uses thereof | |
| BR112017026719B1 (pt) | Complexo de ribonucleoproteína, construto, vetor de expressão, métodos in vitro para modificar um dna ou ácido nucleico alvo, para silenciar a expressão de gene em um locus desejado, para modificar ou deletar e/ou inserir uma sequência de nucleotídeos desejada em um local desejado, e, para detectar e/ou localizar uma mudança de base única em uma molécula de ácido nucleico alvo | |
| HK1231119A1 (en) | Modified cascade ribonucleoproteins and uses thereof |